Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 24401 - 24420 out of 495987 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| Australia | (L04AF03) upadacitinib (adm: O) | Rinvoq 30 mg modified release tablet, 28 | Tablet 30 mg, 28 pcs | Retail price without vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid | AbbViePtyLtd |
| Australia | (L04AF03) upadacitinib (adm: O) | Rinvoq 30 mg modified release tablet, 28 | Tablet 30 mg, 28 pcs | Retail price without vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid | AbbViePtyLtd |
| Australia | (L04AF03) upadacitinib (adm: O) | Rinvoq 30 mg modified release tablet, 28 | Tablet 30 mg, 28 pcs | Retail price without vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid | AbbViePtyLtd |
| Australia | (L04AF03) upadacitinib (adm: O) | Rinvoq 30 mg modified release tablet, 28 | Tablet 30 mg, 28 pcs | Retail price without vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid | AbbViePtyLtd |
| Australia | (L04AF03) upadacitinib (adm: O) | Rinvoq 30 mg modified release tablet, 28 | Tablet 30 mg, 28 pcs | Retail price without vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid | AbbViePtyLtd |
| Australia | (L04AF03) upadacitinib (adm: O) | Rinvoq 30 mg modified release tablet, 28 | Tablet 30 mg, 28 pcs | Retail price without vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid | AbbViePtyLtd |
| Australia | (L04AF03) upadacitinib (adm: O) | Rinvoq 45 mg modified release tablet, 28 | Tablet 45 mg, 28 pcs | Retail price without vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid | AbbViePtyLtd |
| Australia | (L04AF03) upadacitinib (adm: O) | Rinvoq 45 mg modified release tablet, 28 | Tablet 45 mg, 28 pcs | Retail price without vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid | AbbViePtyLtd |
| Australia | (L04AF07) deucravacitinib (adm: O) | Sotyktu 6 mg tablet, 28 | Tablet 6 mg, 28 pcs | Retail price without vat |
$0-0 |
$0-0 |
Psoriasis | Bristol-MyersSquibbAustraliaPtyLtd |
| Australia | (L04AG03) natalizumab (adm: P) | Tysabri 300 mg/15 mL injection, 15 mL vial | Solution concentrate for I.V. infusion 300 mg in 15 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Multiple Sclerosis | BiogenAustraliaPtyLtd |
| Australia | (L04AG03) natalizumab (adm: P) | Tysabri 150 mg/mL injection, 2 x 1 mL syringes | Injection 150 mg in 1 mL single dose pre-filled syringe, 2 pcs | Retail price without vat |
$0-0 |
$0-0 |
Multiple Sclerosis | BiogenAustraliaPtyLtd |
| Australia | (L04AG05) vedolizumab (adm: P) | Entyvio 108 mg/0.68 mL injection, 2 x 0.68 mL pen devices | Injection 108 mg in 0.68 mL single use pre-filled pen, 2 pcs | Retail price without vat |
$0-0 |
$0-0 |
Colitis, Ulcerative;Crohn Disease | TakedaPharmaceuticalsAustraliaPty.Ltd. |
| Australia | (L04AG05) vedolizumab (adm: P) | Entyvio 108 mg/0.68 mL injection, 2 x 0.68 mL pen devices | Injection 108 mg in 0.68 mL single use pre-filled pen, 2 pcs | Retail price without vat |
$0-0 |
$0-0 |
Colitis, Ulcerative;Crohn Disease | TakedaPharmaceuticalsAustraliaPty.Ltd. |
| Australia | (L04AG05) vedolizumab (adm: P) | Entyvio 108 mg/0.68 mL injection, 2 x 0.68 mL pen devices | Injection 108 mg in 0.68 mL single use pre-filled pen, 2 pcs | Retail price without vat |
$0-0 |
$0-0 |
Colitis, Ulcerative;Crohn Disease | TakedaPharmaceuticalsAustraliaPty.Ltd. |
| Australia | (L04AG05) vedolizumab (adm: P) | Entyvio 108 mg/0.68 mL injection, 2 x 0.68 mL pen devices | Injection 108 mg in 0.68 mL single use pre-filled pen, 2 pcs | Retail price without vat |
$0-0 |
$0-0 |
Colitis, Ulcerative;Crohn Disease | TakedaPharmaceuticalsAustraliaPty.Ltd. |
| Australia | (L04AG05) vedolizumab (adm: P) | Entyvio 108 mg/0.68 mL injection, 2 x 0.68 mL pen devices | Injection 108 mg in 0.68 mL single use pre-filled pen, 2 pcs | Retail price without vat |
$0-0 |
$0-0 |
Colitis, Ulcerative;Crohn Disease | TakedaPharmaceuticalsAustraliaPty.Ltd. |
| Australia | (L04AG05) vedolizumab (adm: P) | Entyvio 108 mg/0.68 mL injection, 2 x 0.68 mL pen devices | Injection 108 mg in 0.68 mL single use pre-filled pen, 2 pcs | Retail price without vat |
$0-0 |
$0-0 |
Colitis, Ulcerative;Crohn Disease | TakedaPharmaceuticalsAustraliaPty.Ltd. |
| Australia | (L04AG05) vedolizumab (adm: P) | Entyvio 300 mg powder for injection, 1 vial | Powder for injection 300 mg, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Colitis, Ulcerative;Crohn Disease | TakedaPharmaceuticalsAustraliaPty.Ltd. |
| Australia | (L04AG05) vedolizumab (adm: P) | Entyvio 300 mg powder for injection, 1 vial | Powder for injection 300 mg, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Colitis, Ulcerative;Crohn Disease | TakedaPharmaceuticalsAustraliaPty.Ltd. |
| Australia | (L04AG05) vedolizumab (adm: P) | Entyvio 300 mg powder for injection, 1 vial | Powder for injection 300 mg, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Colitis, Ulcerative;Crohn Disease | TakedaPharmaceuticalsAustraliaPty.Ltd. |
Pages
